The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components

Journal of Molecular Medicine

Volumn 80, Issue 4, 2002, Pages 201-211

  Vogel, Arndt ^a   Strassburg, Christian P ^a   Obermayer Straub, Petra ^a   Brabant, Georg ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

APECED; Autoimmunity; Etiology; Genes; Polymorphisms

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; FAS LIGAND; HLA A ANTIGEN; HLA B ANTIGEN; HLA B8 ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NEUROD BETA2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ADDISON DISEASE; ALOPECIA AREATA; AUTOIMMUNE HEPATITIS; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CHROMOSOME 21; DISEASE COURSE; EXON; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GONADAL DISEASE; HASHIMOTO DISEASE; HETEROZYGOSITY; HUMAN; HYPOPARATHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MUTATION RATE; NONHUMAN; NONSENSE MUTATION; PERNICIOUS ANEMIA; PHENOTYPE; PROTEIN DOMAIN; REVIEW; VITILIGO;

AUTOIMMUNITY; HUMANS; POLYENDOCRINOPATHIES, AUTOIMMUNE; TRANSCRIPTION FACTORS;

EID: 0036236464     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-001-0306-2     Document Type: Review

References (126)

1. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients
2. Clinical review 93: Autoimmune polyglandular syndrome type 1
3. Polyglandular autoimmune syndrome type I among Iranian Jews
4. An autosomal locus causing autoimmune disease: Autoimmune polyglandular disease type I assigned to chromosome 21
5. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients
6. Positional cloning of the APECED gene
7. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
8. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
9. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
10. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy
11. Subcellular localization of the autoimmune regulator protein. Characterization of nuclear targeting and transcriptional activation domain
12. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein
13. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla
14. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1)
15. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway
16. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression
17. Liver disease in polyglandular autoimmune disease type one: Clinicopathologic study of three patients and review of the literature
18. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: Response to immunosuppressive therapy
19. The polyglandular failure syndrome: Disease inheritance, HLA type, and immune function
20. The expression of autoimmune polyglandular disease type I appears associated with several HLAA antigens but not with HLA-DR
21. ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
22. HLA type and occurrence of disease in familial polyglandular failure
23. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome
24. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity
25. Genetic homogeneity of autoimmune polyglandular disease type I
26. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
27. Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein
28. Mutation analyses of North American APS-1 patients
29. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1
30. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins
31. Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED
32. Cloning of the APECED gene provides new insight into human autoimmunity
33. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse
34. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I
35. A prospective cytogenetic study of 36 cases of DiGeorge syndrome
36. GATA3 haplo-insufficiency causes human HDR syndrome
37. The autosomal recessive Kenny-Caffey syndrome locus maps to chromosome 1q42-q43
38. Familial nephrosis, nerve deafness, and hypoparathyroidism
39. Familial isolated hypoparathyroidism: A molecular genetic analysis of 8 families with 23 affected persons
40. A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism
41. Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies
42. Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism
43. Autosomal dominant hypocalcaemia caused by a Ca (2+)-sensing receptor gene mutation
44. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor
45. Mutations in the Ca (2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism
46. Sporadic hypoparathyroidism caused by de Novo gain-of-function mutations of the Ca (2+)-sensing receptor
47. Abdominal tuberculosis-a disease revived
48. X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes
49. Primary adrenal insufficiency in patients with the acquired immunodeficiency syndrome: A report of five cases
50. Eighty-six cases of Addison's disease
51. A novel mutation of the adrenocorticotropin receptor (ACTH-R) gene in a family with the syndrome of isolated glucocorticoid deficiency, but no ACTH-R abnormalities in two families with the triple A syndrome
52. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease
53. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease
54. DRB1*04 and DQ alleles: Expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease
55. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease
56. Major histocompatibility complex class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility
57. HLA associations with autoimmune Addison's disease
58. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease
59. HLA class II antigen associations help to define two types of alopecia areata
60. Alopecia areata in families: Association with the HLA locus
61. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata
62. DNA polymorphism of HLA class II genes in alopecia areata
63. Heritable factors distinguish two types of alopecia areata
64. HLA-DP antigens in patients with alopecia areata
65. Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata
66. Familial alopecia areata: No linkage with HLA
67. Km1 allotype association with one subgroup of alopecia areata
68. Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): Evidence of association with alopecia areata in the Down syndrome region
69. X inactivation in man: A woman with t (Xq-;12q+)
70. The critical region on the human Xq
71. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure
72. Deletion (X)(q26.1->q28) in a proband and her mother: Molecular characterization and phenotypic-karyotypic deductions
73. Molecular and cytogenetic studies of an X;autosome translocation in a patient with premature ovarian failure and review of the literature
74. Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21
75. The X chromosome and ovarian failure
76. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: Evidence for conserved function in oogenesis and implications for human sterility
77. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure
78. The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure
79. Autoimmune regulator AIRE: Evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1
80. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis
81. HLA-C genes and susceptibility to type 1 autoimmune hepatitis
82. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis
83. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients
84. Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis
85. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis
86. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis
87. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis
88. Early-onset autoimmune hepatitis is associated with a C4A gene deletion
89. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis
90. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis
91. Pattern of familial aggregation of vitiligo
92. Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo
93. HLA associations in vitiligo patients in the Dutch population
94. Vitiligo is associated with HLA-A2 and HLA-Dw7 in the Slovak populations
95. Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients
96. HLA antigens in Omani patients with vitiligo
97. HLA-DR patterns in pernicious anaemia
98. HLA antigens in Addisonian pernicious anaemia: Absence of a HLA and disease association
99. A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: No evidence for association
100. Screening for an AIRE-1 mutation in patients with Addison's disease, type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as in APECED syndrome
101. HLA associations with Hashimoto's thyroiditis
102. Genetics of autoimmune thyroid disease: Lack of evidence for linkage to HLA within families
103. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism
104. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: Evidence for genetic heterogeneity and gene interactions
105. Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
106. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus
107. A genome-wide search for human type 1 diabetes susceptibility genes
108. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q
109. A search for type 1 diabetes susceptibility genes in families from the United Kingdom
110. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele
111. Insulin-dependent diabetes mellitus
112. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes study
113. TNFa microsatellite polymorphism modulates the risk of IDDM in Caucasians with the high-risk genotype HLA DQA1*0501-DQB1*0201/DQA1*0301-DQB1*0302
114. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes
115. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM 2 susceptibility locus for type 1 diabetes
116. Fine mapping of the diabetes-susceptibility locus, IDDM 4, on chromosome 11q13
117. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM 12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33
118. NeuroD/BETA2 gene variability and diabetes: No associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes
119. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese
120. Vitamin D deficiency inhibits pancreatic secretion of insulin
121. 1:25-Dihydroxyvitamin D3 prevents insulitis in NOD mice
122. Inhibition of human T lymphocyte proliferation and cytokine production by 1:25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells
123. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans
124. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians
125. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population
126. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians